Results 211 to 220 of about 87,418 (301)

Using unmanned aerial vehicles (drones) to improve access to blood in low‐ and middle‐income countries: Current challenges and opportunities

open access: yesVox Sanguinis, EarlyView.
Abstract Blood transfusion is life‐saving for patients in emergencies, but low‐ and middle‐income countries (LMICs) often face a severe shortage of banked blood. Establishing blood banks in rural areas presents substantial logistical and economic challenges for many LMICs.
Suvro Sankha Datta   +4 more
wiley   +1 more source

Hypoxic‐hypocapnic red blood cells in PAGGSM additive solution before and after gamma irradiation show improved metabolism

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Hypoxic/hypocapnic (HH) treatment and storage conditions have been shown to reduce oxidative stress and improve red blood cell (RBC) quality. This study aimed to validate a good manufacturing practice HH RBC product for obtaining the licence for routine use in patients, by comparison with normoxic RBCs both without ...
Soroth Chey   +3 more
wiley   +1 more source

The THOR network best practices for females of childbearing potential with life‐threatening hemorrhage: Guidance for emergency medical services and hospitals

open access: yes
Transfusion, EarlyView.
Matthew J. Levy   +12 more
wiley   +1 more source

An innovative modelling proposal for the blood supply chain

open access: yesVox Sanguinis, EarlyView.
Abstract Whole‐blood donation and apheresis are the only ways to obtain blood components for human use. Tools are being developed to improve the efficiency of blood donation systems by reducing waste, increasing donations and preventing shortages.
Jorge Pagán‐Ortiz   +4 more
wiley   +1 more source

Rare case of warm IgM autoimmune hemolytic anemia. [PDF]

open access: yesTransfusion
Tordon B   +5 more
europepmc   +1 more source

International multicentre evaluation of a new anti‐idiotypic anti‐daratumumab for resolving pre‐transfusion interferences

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani   +30 more
wiley   +1 more source

Home - About - Disclaimer - Privacy